Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

APR 03, 2013 - Boston Herald

A Must Read - Share

Renamed BIND Therapeutics strikes deal with Pfizer

Cambridge-based biopharmaceutical company BIND Therapeutics said today it has entered into a global collaboration agreement with Pfizer Inc. to develop and commercialize its Accurins therapies.Under terms of the agreement, Pfizer will have the exclusive option to pursue development and commercialization of the Accurins selected by its team. Both companies will work together on preclinical research, and if Pfizer exercises its option, Pfizer will have responsibility for developing and commercializing the selected Accurins.

Tags: Renamed BIND Therapeutics strikes deal with Pfizer,  Pfizer Latest News